Table 1.
Sources of exosomes and their roles in ulcerative colitis
|
Exosomes source
|
Pivotal molecules
|
Role of the exosomes
|
Conclusion
|
Ref.
|
| Stem cell | miR-378a-5p | Inhibiting pyroptosis through NLRP3/caspase-1 signaling | Beneficial | [71] |
| Stem cell | miR-539-5p | Inhibiting pyroptosis through NLRP3/caspase-1 signaling | Beneficial | [72] |
| Stem cell | miRNA | Suppressing pyroptosis | Beneficial | [73] |
| Stem cell | miR-203a-3p.2 | Suppressing macrophage pyroptosis induced by caspase11/4 | Beneficial | [74] |
| Stem cell | NA | Regulating the Treg population | Beneficial | [75] |
| Stem cell | NA | Modulating the gut metagenomics-metabolomics-farnesoid X receptor axis | Beneficial | [76] |
| Stem cell | NA | Polarizing M2b macrophages | Beneficial | [77] |
| Stem cell | miR-146a | Inhibiting SUMO1 expression and its binding to β-catenin | Beneficial | [78] |
| Stem cell | miR-216a-5p | Inducing macrophage M2 polarization by regulating the HMGB1/TLR4/NF-κB signaling pathway | Beneficial | [79] |
| Stem cell | NA | Regulating the Th17/Treg balance | Beneficial | [80] |
| Stem cell | NA | Repairing intestinal barrier via TSG-6 | Beneficial | [81] |
| Stem cell | miR-125a, miR-125b | Repressing Th17 cell differentiation | Beneficial | [82] |
| Stem cell | NA | Limiting intestinal epithelial cells reactive oxygen species accumulation and DNA damage through HIF-1α | Beneficial | [83] |
| Stem cell | miR-181a | Improving gut microbiota composition, barrier function, and inflammatory status | Beneficial | [84] |
| Stem cell | NA | Suppressing inflammation | Beneficial | [85] |
| Stem cell | NA | Modulating Th1/Th17 and Treg cell responses | Beneficial | [86] |
| Stem cell | NA | Attenuating inflammation, oxidative stress and apoptosis | Beneficial | [87] |
| Stem cell | NA | Stimulating epithelial repair and decreasing epithelial apoptosis | Beneficial | [88] |
| Stem cell | NA | Modulating the expression of IL-7 in macrophages | Beneficial | [89] |
| Stem cell | NA | Downregulating intestine ferroptosis | Beneficial | [90] |
| Melatonin and stem cell | NA | Suppressing inflammation, oxidative stress, apoptosis, and fibrosis | Beneficial | [91] |
| Dendritic Cell | miR-146a | Targeting Traf6, IRAK-1, and NLRP3 in macrophages | Beneficial | [92] |
| Dendritic cell | NA | Preventing colon damage | Beneficial | [93] |
| Dendritic cell | NA | Downregulating the expression of IL-2, IFN-γ and TNF-α | Beneficial | [94] |
| Dendritic cell | NA | Carrying drug to dendritic cell | Beneficial | [95] |
| M2 macrophage | miR-590-3p | Suppressing LATS1 and activating the YAP/β-catenin signaling | Beneficial | [96] |
| M1 macrophage | MiR-21a-5p | Decreasing E-cadherin and subsequent ILC2 activation | Unfavorable | [97] |
| Intestinal | NA | Promoting wound healing | Beneficial | [98] |
| Visceral adipose tissue | miR-155 | Promoting macrophage M1 polarization | Unfavorable | [99] |
| Serum | NA | Inhibiting MCP-1 and MIP-1α expression via NLRP12-Notch signaling pathway | Beneficial | [100] |
| Serum | Proteins | Implicating macrophage activation | NA | [101] |
| Helicobacter pylori | NA | Aggravating intestinal epithelium barrier dysfunction by facilitating Claudin-2 expression | Unfavorable | [102] |
| Milk | NA | Suppressing inflammation | Beneficial | [103] |
| Cow and human milk | miRNA-320, 375, and Let-7 | Downregulating DNA methyltransferase 1 (DNMT1) and DNMT3 | Beneficial | [104] |
| Bovine colostrum | NA | Suppressing inflammation and oxidative stress | Beneficial | [105] |
NA: Not available.